Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Retraction: The Dietary Polyphenols trans-Resveratrol and Curcumin Selectively Bind Human CB1 Cannabinoid Receptors with Nanomolar Affinities and Function as Antagonists/Inverse Agonists

Kathryn A. Seely, Mark S. Levi and Paul L. Prather
Journal of Pharmacology and Experimental Therapeutics July 2009, 330 (1) 31-39; DOI: https://doi.org/10.1124/jpet.109.151654
Kathryn A. Seely
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark S. Levi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Prather
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 330 no. 1 31-39
DOI 
https://doi.org/10.1124/jpet.109.151654
PubMed 
19359525

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received January 29, 2009
  • Accepted April 8, 2009
  • Published online June 22, 2009.

Article Versions

  • Earlier version (April 9, 2009 - 11:40).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kathryn A. Seely,
  2. Mark S. Levi and
  3. Paul L. Prather
  1. Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
  1. Address correspondence to:
    Paul L. Prather, Department of Pharmacology and Toxicology, College of Medicine, Slot 611, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205. E-mail: pratherpaull{at}uams.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2009 to May 2023

AbstractFullPdf
Apr 2009890348
May 2009640151
Jun 200919323204
Jul 200918557107
Aug 20091183465
Sep 2009942848
Oct 2009782530
Nov 2009681442
Dec 2009771265
Jan 20101091629
Feb 2010701930
Mar 2010712024
Apr 2010732112
May 2010561016
Jun 2010711722
Jul 2010343929
Aug 2010433824
Sep 2010413822
Oct 2010244926
Nov 2010333439
Dec 2010421814
Jan 2011304534
Feb 2011236134
Mar 2011364344
Apr 2011332737
May 2011423730
Jun 2011331850
Jul 2011333235
Aug 2011292944
Sep 2011215648
Oct 2011323332
Nov 2011383242
Dec 2011211819
Jan 2012383440
Feb 2012404548
Mar 2012474538
Apr 2012314142
May 2012903156
Jun 2012452825
Jul 2012264311
Aug 2012284029
Sep 2012142622
Oct 2012334932
Nov 2012263529
Dec 2012224520
Jan 2013272713
Feb 2013213416
Mar 2013283616
Apr 2013283534
May 2013247130
Jun 2013262913
Jul 201322329
Aug 2013112415
Sep 2013252410
Oct 2013196411
Nov 2013204721
Dec 2013204722
Jan 2014133810
Feb 201415378
Mar 201422339
Apr 2014455824
May 2014324114
Jun 2014145110
Jul 201416696
Aug 2014113911
Sep 201415359
Oct 2014142415
Nov 201417236
Dec 2014428611
Jan 2015153113
Feb 20156206
Mar 2015175115
Apr 201523285
May 2015113411
Jun 20157326
Jul 2015372815
Aug 2015173111
Sep 2015244618
Oct 201528418
Nov 201514247
Dec 2015313212
Jan 2016223711
Feb 2016201910
Mar 2016341618
Apr 2016233020
May 2016166017
Jun 20162110716
Jul 2016124723
Aug 2016142514
Sep 2016223926
Oct 2016119113
Nov 2016119317
Dec 201647722
Jan 2017138637
Feb 201746822
Mar 201797937
Apr 2017306521
May 201744514
Jun 201743619
Jul 201734416
Aug 201793416
Sep 201794328
Oct 201733311
Nov 20170398
Dec 20172359
Jan 2018133219
Feb 20183674
Mar 20187359
Apr 20184478
May 20184386
Jun 20183428
Jul 201823012
Aug 201813112
Sep 201814315
Oct 201875516
Nov 2018115715
Dec 20183869
Jan 20194603
Feb 20193439
Mar 20192282
Apr 201927316
May 20192415
Jun 20192401
Jul 201937310
Aug 20195927
Sep 20193126
Oct 20191716
Nov 20192721
Dec 20191934
Jan 20203302
Feb 20203118
Mar 20202501
Apr 20202813
May 20201512
Jun 20202502
Jul 20201303
Aug 20201912
Sep 20202822
Oct 202045332
Nov 2020244123
Dec 202064116
Jan 202148317
Feb 202143221
Mar 202180223
Apr 202158326
May 202150323
Jun 202168223
Jul 202136327
Aug 202131124
Sep 202150122
Oct 2021321424
Nov 202142021
Dec 202126232
Jan 2022171232
Feb 202246120
Mar 202243424
Apr 202249224
May 202239122
Jun 202216324
Jul 202239126
Aug 202223121
Sep 202252123
Oct 202220020
Nov 202218113
Dec 202221115
Jan 202335315
Feb 202337214
Mar 202353114
Apr 202345615
May 202319111

Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 3
1 Jun 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Retraction: The Dietary Polyphenols trans-Resveratrol and Curcumin Selectively Bind Human CB1 Cannabinoid Receptors with Nanomolar Affinities and Function as Antagonists/Inverse Agonists
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Retraction: The Dietary Polyphenols trans-Resveratrol and Curcumin Selectively Bind Human CB1 Cannabinoid Receptors with Nanomolar Affinities and Function as Antagonists/Inverse Agonists

Kathryn A. Seely, Mark S. Levi and Paul L. Prather
Journal of Pharmacology and Experimental Therapeutics July 1, 2009, 330 (1) 31-39; DOI: https://doi.org/10.1124/jpet.109.151654

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Retraction: The Dietary Polyphenols trans-Resveratrol and Curcumin Selectively Bind Human CB1 Cannabinoid Receptors with Nanomolar Affinities and Function as Antagonists/Inverse Agonists

Kathryn A. Seely, Mark S. Levi and Paul L. Prather
Journal of Pharmacology and Experimental Therapeutics July 1, 2009, 330 (1) 31-39; DOI: https://doi.org/10.1124/jpet.109.151654
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • pH-dependent GPR4 antagonist
  • Antifibrotic DRD1 escapes TGFβ-mediated repression
  • Chlorogenic Acid Inhibits Breast Cancer Metastasis
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics